Concepedia

Philip Parsons

PP

Statistics

Publications

6

Citations

197

H-Index

6

Active since

1984

Affiliations

Velindre Cancer Centre(Current)

University of Leeds

The Christie NHS Foundation Trust

Velindre NHS Trust

University of Oxford

Philip Parsons is an author at Velindre Cancer Centre specializing in oncology, medicine, and lung cancer.

Top concepts

Publications per year

1984–2020

6

Publications

6

Histologic features predictive of an increased risk of early local recurrence after treatment of breast cancer by local tumor excision and radical radiotherapy.

Roger Lindley, A S Bulman, Philip Parsons et al. · PubMed · 1989 · 76 citations

A prospective phase II study of pre-operative chemotherapy then short-course radiotherapy for high risk rectal cancer: COPERNICUS

Simon Gollins, Nicholas P. West, David Sebag‐Montefiore et al. · British Journal of Cancer · 2018 · 39 citations · Full text

Multiple sequential biomarkers in monitoring patients with carcinoma of the lung.

R. S. Aroney, W. C. Dermody, Paul H. Aldenderfer et al. · PubMed · 1984 · 28 citations

, , +14

ARISTOTLE: A phase III trial comparing concurrent capecitabine with capecitabine and irinotecan (Ir) chemoradiation as preoperative treatment for MRI-defined locally advanced rectal cancer (LARC).

David Sebag‐Montefiore, Richard Adams, Simon Gollins et al. · Journal of Clinical Oncology · 2020 · 22 citations

, , +14

Ploidy of Surgically Treated Primary Lung-Cancer

MH Bint, G. A. T. Hawson, P.V. Zimmerman et al. · Queensland's institutional digital repository (The University of Queensland) · 1987 · 16 citations

, , +4

1–5 of 6